Keiichi Ozono Selected Research

Growth Hormone (Somatotropin)

1/2022	Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
1/2018	Responses to the Letter to the Editor "Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially ?" (Vol. 27, No. 2, p. 107-108, 2018).
1/2017	Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS).
10/2012	Pediatric aspects of skeletal dysplasia.
4/2012	Favorable impact of growth hormone treatment on cholesterol levels in turner syndrome.
9/2006	[Ectopic growth hormone-producing tumor].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keiichi Ozono Research Topics

Disease

26	Hypophosphatasia 03/2024 - 05/2005
23	Neoplasms (Cancer) 02/2023 - 01/2006
19	Rickets (Rachitis) 05/2022 - 06/2010
16	Hypophosphatemia 02/2024 - 01/2002
13	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 02/2024 - 01/2005
12	Osteomalacia 01/2020 - 01/2007
10	Achondroplasia 04/2024 - 10/2012
10	Hypocalcemia 11/2023 - 12/2005
10	Infections 10/2018 - 05/2007
8	Hypercalcemia (Milk Alkali Syndrome) 01/2017 - 12/2005
7	Vitamin D Deficiency 05/2021 - 01/2003
7	Bone Resorption 05/2015 - 05/2008
6	Bone Diseases (Bone Disease) 01/2020 - 01/2009
6	Globoid Cell Leukodystrophy (Krabbe Disease) 06/2018 - 04/2005
5	Hyperphosphatemia 11/2023 - 08/2007
5	Wilms Tumor (Wilm's Tumor) 02/2023 - 06/2006
5	Osteogenesis Imperfecta (Lobstein Disease) 01/2023 - 09/2011
5	Pain (Aches) 01/2023 - 01/2017
5	Metabolic Bone Diseases (Osteopenia) 04/2019 - 01/2006
5	Hypoxia (Hypoxemia) 04/2016 - 04/2007
5	Mucolipidoses (Sialidosis) 02/2012 - 03/2009
4	Osteoporosis 03/2024 - 01/2006
4	Metabolic Diseases (Metabolic Disease) 12/2020 - 09/2008
4	Down Syndrome (Down's Syndrome) 01/2020 - 02/2008
4	Hypophosphatemic Rickets 05/2017 - 01/2013
4	Secondary Hyperparathyroidism 01/2017 - 01/2006
4	Demyelinating Diseases (Demyelinating Disease) 01/2014 - 04/2005
3	Hypoparathyroidism 11/2023 - 10/2008
3	Pseudohypoparathyroidism 11/2023 - 01/2017
3	Leukemia 02/2023 - 01/2009
3	Hypersensitivity (Allergy) 01/2023 - 07/2008
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 04/2010
3	Inflammation (Inflammations) 10/2022 - 04/2006
3	Disease Progression 11/2021 - 09/2017
3	Hypertension (High Blood Pressure) 10/2021 - 06/2005
3	Mucopolysaccharidoses 09/2021 - 02/2012
3	Seizures (Absence Seizure) 06/2021 - 12/2011
3	Congenital Abnormalities (Deformity) 03/2020 - 02/2019
3	Allan-Herndon-Dudley syndrome 01/2019 - 07/2008
3	Pulmonary Arterial Hypertension 01/2016 - 01/2013
3	Hypercalciuria 12/2013 - 06/2004
3	Fibrosis (Cirrhosis) 12/2012 - 11/2003
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2009 - 03/2009
3	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 07/2009 - 01/2002
2	Body Weight (Weight, Body) 04/2024 - 04/2012
2	Fatigue 03/2024 - 01/2022
2	Pneumonia (Pneumonitis) 01/2024 - 01/2009
2	Injection Site Reaction 01/2024 - 01/2023

Drug/Important Bio-Agent (IBA)

21	Alkaline PhosphataseIBA 03/2024 - 05/2005
18	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 03/2024 - 01/2016
17	Fibroblast Growth Factor-23IBA 02/2024 - 01/2005
17	CalciumIBA 01/2020 - 06/2004
16	Vitamin D FDA LinkGeneric 02/2024 - 01/2003
16	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
14	Phosphates (Orthophosphate)IBA 01/2023 - 01/2005
8	MineralsIBA 03/2024 - 10/2012
8	Hormones (Hormone)IBA 01/2018 - 08/2007
8	EnzymesIBA 01/2017 - 03/2009
7	vosoritideIBA 04/2024 - 01/2020
7	asfotase alfaIBA 03/2024 - 01/2016
6	Growth Hormone (Somatotropin)IBA 01/2022 - 09/2006
5	Parathyroid Hormone (Parathormone)IBA 11/2023 - 01/2007
5	Peptides (Polypeptides)IBA 02/2023 - 11/2003
5	1,25-dihydroxyvitamin DIBA 07/2021 - 01/2005
5	hydroxide ionIBA 05/2017 - 04/2004
4	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2024 - 05/2015
4	burosumabIBA 01/2023 - 02/2019
4	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2018
4	25-hydroxyvitamin DIBA 07/2021 - 01/2006
4	4-phenylbutyric acid (Buphenyl)FDA Link 01/2021 - 07/2014
4	Thyroid HormonesIBA 01/2019 - 07/2008
4	Dihydrotachysterol (AT 10)IBA 10/2016 - 01/2005
3	PHEX Phosphate Regulating Neutral EndopeptidaseIBA 02/2024 - 01/2020
3	VaccinesIBA 02/2023 - 08/2010
3	AntigensIBA 01/2023 - 04/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 04/2005
3	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 12/2021 - 10/2012
3	GlycosaminoglycansIBA 09/2021 - 02/2012
3	CreatinineIBA 07/2021 - 12/2013
3	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2008
3	Diphosphonates (Bisphosphonates)IBA 05/2019 - 01/2006
3	Pamidronate (Aredia)FDA LinkGeneric 05/2019 - 09/2011
3	Psychosine (Galactosylsphingosine)IBA 06/2018 - 04/2005
3	GalactosylceramidaseIBA 06/2018 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 07/2008 - 11/2002
2	GlucocorticoidsIBA 03/2024 - 07/2014
2	SteroidsIBA 03/2024 - 01/2007
2	WT1 ProteinsIBA 02/2023 - 01/2023
2	Interferon-gamma (Interferon, gamma)IBA 02/2023 - 01/2022
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2023 - 05/2017

Therapy/Procedure

36	Therapeutics 04/2024 - 01/2002
11	Hematopoietic Stem Cell Transplantation 10/2016 - 12/2008
7	Drug Therapy (Chemotherapy) 01/2020 - 12/2008
5	Immunotherapy 01/2023 - 01/2009
5	Transplantation 01/2023 - 09/2008
4	Enzyme Replacement Therapy 07/2023 - 02/2014
4	Heart Transplantation (Grafting, Heart) 01/2023 - 03/2009
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2014 - 10/2007
2	Phototherapy (Light Therapy) 05/2023 - 01/2023
2	Oral Administration 02/2023 - 01/2006